Comment by AcornAl on 02/01/2025 at 20:22 UTC

10 upvotes, 0 direct replies (showing 0)

View submission: Bismuth subsalicylate as potential treatment for Covid-19 pneumonia: A case series report

Can I ask why you are posting old studies to multiple subs about a drug candidate that has never had a single clinical trial? It's just one of a couple dozen candidates[1] that could be used to inhibit the SARS-CoV-2 protease similar to nirmatrelvir + ritonavir.

1: https://pubs.acs.org/doi/full/10.1021/acsomega.4c03023

While this particular drug has been shown to have an antiviral effect, it has limited bioavailability[2] that will probably mean that it will not be a viable medication in it's current form.

2: https://www.mdpi.com/1420-3049/28/15/5921

Replies

There's nothing here!